ICU Medical, Inc. (NASDAQ:ICUI) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of ICU Medical, Inc. (NASDAQ:ICUI) have received a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $177.25.

Several brokerages recently weighed in on ICUI. Raymond James upped their price objective on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price on the stock in a research report on Wednesday. KeyCorp increased their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th.

ICU Medical Stock Performance

Shares of NASDAQ:ICUI opened at $165.59 on Friday. ICU Medical has a 1 year low of $85.64 and a 1 year high of $196.26. The stock has a market capitalization of $4.05 billion, a price-to-earnings ratio of -36.23 and a beta of 0.62. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The company’s 50 day simple moving average is $171.48 and its 200 day simple moving average is $150.56.

Insider Transactions at ICU Medical

In related news, Director David C. Greenberg sold 972 shares of ICU Medical stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total value of $153,682.92. Following the completion of the sale, the director now owns 5,037 shares of the company’s stock, valued at approximately $796,400.07. This trade represents a 16.18 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction on Friday, November 1st. The shares were sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at $17,973,261.12. This trade represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 40,364 shares of company stock worth $6,869,878 over the last ninety days. 6.70% of the stock is owned by insiders.

Institutional Trading of ICU Medical

Hedge funds have recently bought and sold shares of the business. CWM LLC raised its stake in shares of ICU Medical by 18.5% in the second quarter. CWM LLC now owns 767 shares of the medical instruments supplier’s stock valued at $91,000 after buying an additional 120 shares during the period. SG Americas Securities LLC lifted its stake in shares of ICU Medical by 441.7% during the 2nd quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier’s stock valued at $691,000 after buying an additional 4,744 shares in the last quarter. Blue Trust Inc. boosted its holdings in ICU Medical by 384.4% in the 2nd quarter. Blue Trust Inc. now owns 1,090 shares of the medical instruments supplier’s stock worth $129,000 after buying an additional 865 shares during the period. Nisa Investment Advisors LLC grew its stake in ICU Medical by 3.2% in the 2nd quarter. Nisa Investment Advisors LLC now owns 10,939 shares of the medical instruments supplier’s stock valued at $1,299,000 after buying an additional 339 shares in the last quarter. Finally, Kirr Marbach & Co. LLC IN raised its holdings in ICU Medical by 5.6% during the 2nd quarter. Kirr Marbach & Co. LLC IN now owns 23,809 shares of the medical instruments supplier’s stock valued at $2,827,000 after acquiring an additional 1,269 shares during the period. 96.10% of the stock is currently owned by institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.